Artificial Intelligence Ventus Therapeutics | Developing Small Molecule Medicines


Enterprise, Biotechnology, Pharmaceuticals, Life Science, Drug Discovery, Immunology Montreal, QC, Canada

Ventus Therapeutics

Artificial Intelligence


Ventus Therapeutics | Developing Small Molecule Medicines

Ventus Therapeutics

Biotechnology, Pharmaceuticals, Life Science, Drug Discovery, Immunology


Montreal, QC, Canada

At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but elusive, drug targets.  Using two platforms, we expand the set of targets amenable to small-molecule medicines including targets that have never been drugged and others for which existing chemical matter leaves significant room for improvement.

Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Our structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system. Advancing the next frontier for structure-based drug design to navigate elusive targets, in Montreal and Waltham, MA.

 

B2B

26 to 50

Series B

$160 M

Scaling Up

2019

 
 

Healthcare
Biotechnology
Pharmaceuticals

N/A

Increase Efficiency

 
 

Production

Yes

Active

 
 

N/A


Biotechnology

Biotechnology

Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


N/A

 
 

View All

Executive Director, Head of Medicinal Chemistry

Waltham, Massachusetts

Executive Director, Head of Medicinal Chemistry

Montreal, Quebec

Director of Human Resources

Montreal, Quebec

 

AI/ML Professionals

Want to work at Ventus Therapeutics?

We can introduce you to the right person at Ventus Therapeutics

Talk to our Talent Team

 

7

1

$100M

Company was founded 2019 and it took almost 2 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/08/2021

Series B

$100M

Biotechnology Value Fund, Casdin Capital, Cormorant Asset Management, Fonds de solidarite FTQ, GV, RA Capital Management, Versant Ventures

Date : 04/08/2021

Round: Series B

$ Raised: $100M

Investors: Biotechnology Value Fund, Casdin Capital, Cormorant Asset Management, Fonds de solidarite FTQ, GV, RA Capital Management, Versant Ventures

 

Investors

Interested in researching Ventus Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Ventus Therapeutics

Request a Demo - Deal Souring Platform

 
Marcelo Bigal


Marcelo Bigal
President and CEO

Dan Koerwer


Dan Koerwer
Chief Business Officer

Zack McNealy


Zack McNealy
CFO

Michael Crackower


Michael Crackower
Chief Scientific Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Ventus Therapeutics